The Liver Meeting® 2018 – The 69th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)

Event Date: November 8 - 13, 2018

Event Location: Booth 601, Moscone Center, 747 Howard St Fl 5, San Francisco, CA 94103

Diapharma will attend and exhibit at The Liver Forum and The Liver Meeting (AASLD) this year. Booth 601. Please click here to schedule a meeting with us or email us directly.

About The Liver Meeting

The Liver Meeting® provides a forum for the exchange of basic, translational and clinical research in diseases of the liver and biliary tract, and in liver transplantation. The Liver Meeting® creates an arena for the presentation and interchange of opinions on state-of-the-art care and management of the full spectrum of patients with liver disease.

Topics

AASLD / ILTS Transplant Course
Liver Transplant Oncology
Cholestatic and Autoimmune Liver Diseases
Associated Liver Disease
Pediatric Liver Disorders
HCV
AASLD / ASGE Endoscopy Course
Precision Medicine in Hepatology
AASLD / NASPGHAN Pediatric Symposium
Liver Disease in the Perinatal Period
Herbal and Dietary Supplement Induced Liver Injury
Genetics and Epigenetics in NAFLD
ACLF (Acute on Chronic Liver Failure)
Liver Cell Biology in Hepatic Diseases
Surgery and Liver Transplant Committee and Liver Transplantation and Surgery
Matrix Biology and the Liver
Cell Death Pathways and Mediators in Liver Disease
Alcoholic Liver Disease
Hepatobiliary Neoplasia
Clinical Hepatology

About the AASLD

The mission of the American Association for the Study of Liver Diseases (AASLD) is to advance the science of hepatology and to promote liver health.

AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. AASLD fosters research that leads to improved treatment options for millions of liver disease patients. AASLD advances the science and practice of hepatology through meetings such as The Liver Meeting®, educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies.